Profilo
Jim Scully served as the Chief Executive & Accounting Officer at Seneca Biopharma, Inc. from 2018 to 2019.
He holds an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Precedenti posizioni note di Jim Scully
| Società | Posizione | Fine |
|---|---|---|
| PALISADE BIO, INC. | Amministratore Delegato | 01/01/2019 |
Formazione di Jim Scully
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
- Borsa valori
- Insiders
- Jim Scully
